NCT05043220View on ClinicalTrials.gov

Covid-19 Predictors: Safety of Gynecological Oncology Patients Undergoing Systemic Cancer Therapy

NAActive, not recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 29, 2021

Primary Completion Date

October 31, 2022

Study Completion Date

April 30, 2025

Conditions
Telemedicine
Interventions
DEVICE

PPG and PROM

description will follow

Trial Locations (1)

81675

Klinikum rechts der Isar, Frauenklinik, Technische Universität München, Munich

All Listed Sponsors
lead

Technical University of Munich

OTHER